Subjects with MDS-f had a higher prevalence of U2AF1 mutations (40% versus 21%; P = 0.01) and lower prevalence of RUNX1 mutations (7% versus 24%; P = 0.01) compared with subjects with MDS-IB. The gene discussed is RUNX1; the disease is myelodysplastic syndrome.